These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines. Taylor J; Paoletti E Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866 [TBL] [Abstract][Full Text] [Related]
7. Replicating and host-restricted non-replicating vaccinia virus vectors for vaccine development. Moss B Dev Biol Stand; 1994; 82():55-63. PubMed ID: 7958483 [TBL] [Abstract][Full Text] [Related]
8. Stability of recombinant vaccinia-rabies vaccine in veterinary use. Pastoret PP; Brochier B; Languet B; Duret C; Chappuis G; Desmettre P Dev Biol Stand; 1996; 87():245-9. PubMed ID: 8854024 [TBL] [Abstract][Full Text] [Related]
9. Target and non-target effects of a recombinant vaccinia-rabies virus developed for fox vaccination against rabies. Pastoret PP; Brochier B; Boulanger D Dev Biol Stand; 1995; 84():183-93. PubMed ID: 7796953 [No Abstract] [Full Text] [Related]
10. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals. Lodmell DL; Esposito JJ; Ewalt LC Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356 [TBL] [Abstract][Full Text] [Related]
11. Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain. Wang Y; Kan S; Du S; Qi Y; Wang J; Liu L; Ji H; He D; Wu N; Li C; Chi B; Li X; Jin N Antiviral Res; 2012 Dec; 96(3):324-32. PubMed ID: 23084929 [TBL] [Abstract][Full Text] [Related]
12. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication. Verardi PH; Titong A; Hagen CJ Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090 [TBL] [Abstract][Full Text] [Related]
13. Infectivity of attenuated poxvirus vaccine vectors and immunogenicity of a raccoonpox vectored rabies vaccine in the Brazilian Free-tailed bat (Tadarida brasiliensis). Stading BR; Osorio JE; Velasco-Villa A; Smotherman M; Kingstad-Bakke B; Rocke TE Vaccine; 2016 Oct; 34(44):5352-5358. PubMed ID: 27650872 [TBL] [Abstract][Full Text] [Related]
14. Vaccinia and other poxvirus expression vectors. Moss B Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937 [TBL] [Abstract][Full Text] [Related]
17. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244 [TBL] [Abstract][Full Text] [Related]
18. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. McCurdy LH; Larkin BD; Martin JE; Graham BS Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622 [TBL] [Abstract][Full Text] [Related]
19. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Moss B Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11341-8. PubMed ID: 8876137 [TBL] [Abstract][Full Text] [Related]
20. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]